
EXECUTIVE SUMMARY
================
Analysis: conservative_value_screen
Date: 2025-08-12 22:31
Description: Conservative value investing screen focusing on quality companies at reasonable prices

RESULTS OVERVIEW
---------------
• Total Universe Screened: 29 stocks
• Passed Initial Screening: 5 stocks
• Final Recommendations: 5 stocks
• Success Rate: 17.2%

AVERAGE QUALITY METRICS
----------------------
• Quality Score: 65.0/100
• Value Score: 56.7/100
• Growth Score: 85.0/100
• Risk Score: 16.4/100

TOP RECOMMENDATIONS
------------------
1. GOOGL - Score: 78.9 (Communication Services)
2. UNH - Score: 76.1 (Healthcare)
3. JNJ - Score: 72.4 (Healthcare)
4. ABBV - Score: 69.2 (Healthcare)
5. PG - Score: 54.8 (Consumer Defensive)

SECTOR BREAKDOWN
---------------
• Healthcare: 3 stocks
• Communication Services: 1 stocks
• Consumer Defensive: 1 stocks

KEY INSIGHTS
-----------
• Found 5 stocks meeting criteria
• Average composite score: 70.3
• Most represented sector: Healthcare

==================================================
Generated by Systematic Investment Analysis Framework



SCREENING PROCESS SUMMARY
========================

FILTERING RESULTS
----------------
• Started with 29 stocks in universe
• 5 passed initial screening criteria
• 5 included in final analysis

SCORE DISTRIBUTIONS
------------------
Quality Scores:  Min: 50.0  Max: 100.0  Avg: 65.0
Value Scores:    Min: 33.3  Max: 100.0  Avg: 56.7
Growth Scores:   Min: 75.0  Max: 100.0  Avg: 85.0
Risk Scores:     Min: 7.2  Max: 26.5  Avg: 16.4

MOST COMMON CONCERNS
-------------------
• Current: 4 occurrences
• P/B: 3 occurrences
• Debt/Equity: 3 occurrences
• EV/EBITDA: 2 occurrences
• Earnings: 2 occurrences

==================================================


DETAILED STOCK ANALYSIS
==================================================


DETAILED ANALYSIS: GOOGL
==================================================

COMPANY OVERVIEW
---------------
• Sector: Communication Services
• Industry: Internet Content & Information
• Market Cap: $2462.65B
• Current Price: $203.34

COMPOSITE SCORING
----------------
• Overall Score: 78.9/100
• Quality Score: 100.0/100
• Value Score: 33.3/100  
• Growth Score: 100.0/100
• Risk Score: 7.2/100

QUALITY ANALYSIS
---------------
• ROIC: 31.2%
• ROE: 34.8%
• Current Ratio: 1.90
• Debt/Equity: 11.5

VALUE ANALYSIS
-------------
• P/E Ratio: 21.7
• P/B Ratio: 6.78
• EV/EBITDA: 16.9
• EV/EBIT: 21.9
Value Concerns:
  ⚠ P/B 6.78 above threshold 3.50
  ⚠ EV/EBITDA 16.9 above threshold 15.0

GROWTH ANALYSIS
--------------
• Revenue Growth: 13.8%
• Earnings Growth: 22.3%
• FCF Growth: 20.1%
• Growth Quality: margin_expanding

RISK ANALYSIS
------------
• Risk Level: LOW
• Financial Risk: 0.0/100
• Estimated Beta: 1.08
• Business Risk: 20.0/100
• Sector Risk: moderate

VALUATION RESULTS
----------------
• RIM Model:
  - Fair Value: $193.17
  - Current Price: $203.34
  - Upside/Downside: -5.0%
  - Confidence: medium

==================================================



DETAILED ANALYSIS: UNH
==================================================

COMPANY OVERVIEW
---------------
• Sector: Healthcare
• Industry: Healthcare Plans
• Market Cap: $237.28B
• Current Price: $261.57

COMPOSITE SCORING
----------------
• Overall Score: 76.1/100
• Quality Score: 50.0/100
• Value Score: 100.0/100  
• Growth Score: 75.0/100
• Risk Score: 17.5/100

QUALITY ANALYSIS
---------------
• ROIC: 12.3%
• ROE: 21.7%
• Current Ratio: 0.85
• Debt/Equity: 75.6
Quality Concerns:
  ⚠ Current ratio 0.85 below threshold 1.20
  ⚠ Debt/Equity 0.76 above threshold 0.60

VALUE ANALYSIS
-------------
• P/E Ratio: 11.3
• P/B Ratio: 2.37
• EV/EBITDA: 8.4
• EV/EBIT: 10.9

GROWTH ANALYSIS
--------------
• Revenue Growth: 12.9%
• Earnings Growth: -17.6%
• FCF Growth: -15.8%
• Growth Quality: margin_contracting
Growth Concerns:
  ⚠ Earnings growth -17.6% below threshold 5.0%

RISK ANALYSIS
------------
• Risk Level: LOW
• Financial Risk: 40.0/100
• Estimated Beta: 0.90
• Business Risk: 10.0/100
• Sector Risk: low

VALUATION RESULTS
----------------
• RIM Model:
  - Fair Value: $248.49
  - Current Price: $261.57
  - Upside/Downside: -5.0%
  - Confidence: medium

==================================================



DETAILED ANALYSIS: JNJ
==================================================

COMPANY OVERVIEW
---------------
• Sector: Healthcare
• Industry: Drug Manufacturers - General
• Market Cap: $416.11B
• Current Price: $172.78

COMPOSITE SCORING
----------------
• Overall Score: 72.4/100
• Quality Score: 50.0/100
• Value Score: 66.7/100  
• Growth Score: 100.0/100
• Risk Score: 17.5/100

QUALITY ANALYSIS
---------------
• ROIC: 18.3%
• ROE: 30.2%
• Current Ratio: 1.01
• Debt/Equity: 64.7
Quality Concerns:
  ⚠ Current ratio 1.01 below threshold 1.20
  ⚠ Debt/Equity 0.65 above threshold 0.60

VALUE ANALYSIS
-------------
• P/E Ratio: 18.5
• P/B Ratio: 5.30
• EV/EBITDA: 14.9
• EV/EBIT: 19.4
Value Concerns:
  ⚠ P/B 5.30 above threshold 3.50

GROWTH ANALYSIS
--------------
• Revenue Growth: 5.8%
• Earnings Growth: 18.7%
• FCF Growth: 16.8%
• Growth Quality: margin_expanding

RISK ANALYSIS
------------
• Risk Level: LOW
• Financial Risk: 40.0/100
• Estimated Beta: 0.90
• Business Risk: 10.0/100
• Sector Risk: low

VALUATION RESULTS
----------------
• RIM Model:
  - Fair Value: $164.14
  - Current Price: $172.78
  - Upside/Downside: -5.0%
  - Confidence: medium

==================================================



DETAILED ANALYSIS: ABBV
==================================================

COMPANY OVERVIEW
---------------
• Sector: Healthcare
• Industry: Drug Manufacturers - General
• Market Cap: $350.91B
• Current Price: $198.64

COMPOSITE SCORING
----------------
• Overall Score: 69.2/100
• Quality Score: 75.0/100
• Value Score: 50.0/100  
• Growth Score: 75.0/100
• Risk Score: 13.5/100

QUALITY ANALYSIS
---------------
• ROIC: 112.9%
• ROE: 112.9%
• Current Ratio: 0.74
• Debt/Equity: 0.0
Quality Concerns:
  ⚠ Current ratio 0.74 below threshold 1.20

VALUE ANALYSIS
-------------
• P/E Ratio: 94.1
• P/B Ratio: -1910.00
• EV/EBITDA: 14.8
• EV/EBIT: 19.2
Value Concerns:
  ⚠ P/E 94.1 above threshold 25.0

GROWTH ANALYSIS
--------------
• Revenue Growth: 6.6%
• Earnings Growth: -32.4%
• FCF Growth: -29.2%
• Growth Quality: margin_contracting
Growth Concerns:
  ⚠ Earnings growth -32.4% below threshold 5.0%

RISK ANALYSIS
------------
• Risk Level: LOW
• Financial Risk: 30.0/100
• Estimated Beta: 0.90
• Business Risk: 10.0/100
• Sector Risk: low

VALUATION RESULTS
----------------
• RIM Model:
  - Fair Value: $188.71
  - Current Price: $198.64
  - Upside/Downside: -5.0%
  - Confidence: medium

==================================================



DETAILED ANALYSIS: PG
==================================================

COMPANY OVERVIEW
---------------
• Sector: Consumer Defensive
• Industry: Household & Personal Products
• Market Cap: $363.28B
• Current Price: $155.09

COMPOSITE SCORING
----------------
• Overall Score: 54.8/100
• Quality Score: 50.0/100
• Value Score: 33.3/100  
• Growth Score: 75.0/100
• Risk Score: 26.5/100

QUALITY ANALYSIS
---------------
• ROIC: 18.4%
• ROE: 31.2%
• Current Ratio: 0.70
• Debt/Equity: 69.9
Quality Concerns:
  ⚠ Current ratio 0.70 below threshold 1.20
  ⚠ Debt/Equity 0.70 above threshold 0.60

VALUE ANALYSIS
-------------
• P/E Ratio: 23.8
• P/B Ratio: 7.09
• EV/EBITDA: 16.0
• EV/EBIT: 20.8
Value Concerns:
  ⚠ P/B 7.09 above threshold 3.50
  ⚠ EV/EBITDA 16.0 above threshold 15.0

GROWTH ANALYSIS
--------------
• Revenue Growth: 1.7%
• Earnings Growth: 16.5%
• FCF Growth: 14.9%
• Growth Quality: margin_expanding
Growth Concerns:
  ⚠ Revenue growth 1.7% below threshold 3.0%

RISK ANALYSIS
------------
• Risk Level: LOW
• Financial Risk: 55.0/100
• Estimated Beta: 0.90
• Business Risk: 20.0/100
• Sector Risk: moderate

VALUATION RESULTS
----------------
• RIM Model:
  - Fair Value: $147.34
  - Current Price: $155.09
  - Upside/Downside: -5.0%
  - Confidence: medium

==================================================
